Recruiting
Phase 2

Anifrolumab

Sponsor:

University of North Carolina, Chapel Hill

Code:

NCT06374212

Conditions

Hidradenitis Suppurativa

Acne Inversa

Hidradenitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-26. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2024-07-24.